1948
19712
Nippon India Pharma Fund Growth
24.08
9.70
13.73
1.32
8.17
8.44
4.96
19.97
https://storage.googleapis.com/5paisa-prod-storage/files/2024-06/nippon-india-mf_0.png
7
1.9
13.73
Nippon India Pharma Fund (G)
1.9
13.73
1.19
3.5
5 Years
Nippon India Pharma Fund Growth
-
NAV
544.94
15 May 2026
-
0.42%
1 Day
-
24.08%
3Y CAGR returns
One click to compare funds with our smart tool—analyze returns & more!
Compare
-
₹ 100
Min SIP -
₹ 5000
Min Lumpsum -
2.32%
Expense Ratio -
8,365 Cr
Fund Size -
22 Years
Fund Age
SIP Calculator
₹
₹
Yr
- Invested Amount
- ₹ 00
- Wealth Gained
- ₹ 00
- Expected Amount
- ₹ 00
₹
Yr
- Invested Amount
- ₹ 00
- Wealth Gained
- ₹ 00
- Expected Amount
- ₹ 00
Returns and Ranks ( as on 15 May 2026 )
- 1Y Returns
- 3Y Returns
- 5Y Returns
- MAX Returns
- Trailing Returns
- 9.70%
- 24.08%
- 13.73%
- 19.97
- 13.76Alpha
- 4.53SD
- 0.75Beta
- 0.90Sharpe
- Exit Load
- 1% if redeemed or switched out on or before completion of 1 Months from the date of allotment of units. Nil if redeemed or switched out after the completion of 1 Months from the date of allotment of units.
- Tax implication
- Returns redeemed within a year are taxed at 20%, while those held longer incur a 12.5% LTCG tax on gains over Rs 1.25 lakh per financial year.
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
Low
Low to
moderate Moderate Moderately
High High Very
High
moderate Moderate Moderately
High High Very
High
- Fund Name
-
- Equity
- Sectoral / Thematic
- Fund Size (Cr.) - ₹ 5,789
-
- Equity
- Sectoral / Thematic
- Fund Size (Cr.) - ₹ 7,707
-
- Equity
- Sectoral / Thematic
- Fund Size (Cr.) - ₹ 8,535
-
- Equity
- Sectoral / Thematic
- Fund Size (Cr.) - ₹ 8,365
19712
- Fund Name
-
- Equity
- Sectoral / Thematic
- AUM - ₹ 1,139
-
Nippon India Silver ETF
- 52.42
-
- Other
- ETFs Fund
- AUM - ₹ 31,126
-
- Other
- FoFs Domestic
- AUM - ₹ 4,380
-
- Other
- ETFs Fund
- AUM - ₹ 55,540
-
- Other
- FoFs Domestic
- AUM - ₹ 7,179
- Address :
- 4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
-
- Contact :
- +91022-68087000/1860260111
-
- Email ID :
- customercare@nipponindiaim.in
Mutual Fund by Category
Large Cap
- Fund Name
Quant Large Cap Fund Growth
- 14.91%
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 3,112
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 51,690
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 213
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 1,722
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 75,650
Mid Cap
Multi Cap
ELSS
Focused
Sectoral / Thematic
Small Cap
Dividend Yield
Ultra Short Duration
Liquid Mutual
Gilt Mutual
Long Duration
Overnight Mutual
Floater Mutual
Arbitrage Mutual
Equity Savings Mutual
Aggressive Hybrid Mutual
Other Calculators
FAQs
Nippon India Pharma Fund Growth has delivered 19.95% since inception
The NAV of Nippon India Pharma Fund Growth is ₹542.651 as of 15 May 2026
The expense ratio of Nippon India Pharma Fund Growth is 2.32 % as of 15 May 2026
The AUM of Nippon India Pharma Fund Growth 8365.4 CR as of 15 May 2026
The minimum SIP amount of Nippon India Pharma Fund Growth is 100
The top stock holdings of Nippon India Pharma Fund Growth are
- Sun Pharma.Inds. - 13.85%
- Lupin - 7.95%
- Dr Reddy's Labs - 7.04%
- Divi's Lab. - 6.61%
- Cipla - 5.47%
The top sectors Nippon India Pharma Fund Growth has invested in are
- - 0%